/PRNewswire/ Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expand the instructions for use.
A study has found that the WATCHMAN FLX left atrial appendage closure device is an effective alternative to oral anticoagulation in patients with postablation AF.
Dublin, June 22, 2022 (GLOBE NEWSWIRE) The "Global Electrophysiology Market Size, Share & Industry Trends Analysis Report By Type, By End User, By.